Rajagopalan Harith 4

What Happened Harith Rajagopalan, CEO of Fractyl Health, purchased 25,000 shares of the company's common stock in open-market transactions on June 10, 2026. The filing reports a weighted average price of $0.73 per share for a total purchase value of $18,253. This was a purchase (transaction code P), which is a direct acquisition of shares rather than a sale or option exercise.

Key Details

• Transaction date: 2026-06-10 (filed on 2026-06-11).
• Transaction type: Open market purchase (Footnote F1); transaction code P = Purchase.
• Price: Weighted average $0.73/share (Column 4); purchases occurred at prices ranging from $0.7213 to $0.7324 (Footnote F2). Reporting person can provide a per-trade breakdown on request.
• Total shares bought: 25,000; total reported value: $18,253.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Additional note: Footnote F3 indicates inclusion of 13,812 shares acquired under the issuer’s 2024 ESPP on Jan 30, 2026 at $0.391/share.
• Filing timeliness: Filed next day (2026-06-11) for the 2026-06-10 transaction — within normal Form 4 timing requirements.

Context Open-market purchases like this represent a direct insider buy but are small in dollar terms (~$18k). The weighted-average price and range show the purchase happened across multiple trades; no options were exercised and no shares were sold in this filing. For investors, insider purchases can be a positive signal, but this single, modest transaction should be weighed with other insider activity and company fundamentals.